"For example, in one study conducted by IQVIA, a large pharma company recruited more than 40,000 patients to a vaccine trial in just eight weeks while exceeding its diversity goals. This success resulted from upfront planning that included diversity-informed site selection, clear goal setting with individual sites, targeted outreach efforts and careful monitoring of the recruiting funnel to ensure diverse populations had the chance to participate. "The bottom line: when we are all working in the same direction, with intention – we've seen success. ACRO and its member companies are committed to working with our research partners to build on that success and help bring about sustainable change."